The median age at diagnosis of adult H3 K27M-mutant gliomas was 32 years, with a midline location (spinal cord, thalamus, brainstem, or cerebellum); at molecular level, these tumors had a low rate of MGMT promoter methylation and lacked EGFR amplification [65]. The gene discussed is MGMT; the disease is central nervous system cancer.